A virtual run has been launched in the UK inspired by a prominent Canadian cancer research activist, to raise money for the Institute of Cancer Research, London.
The LGBT+ network at the ICR and The Royal Marsden is celebrating Pride a little differently this year.
Christine is being treated for secondary breast cancer with the innovative new drug palbociclib.
Dr George Poulogiannis and colleagues found that targeting cancer’s ability to process fat using a new class of drugs could halt tumour growth in mice, but only when combined with a diet free of fats.
Thanks to abiraterone – a drug discovered and developed by the ICR – Rob’s been living well with prostate cancer for seven and a half years.
Professor Ian Collins talks about our drug discovery work - including the formation of a new spinout company.
We are creating a new state-of-the-art drug discovery centre to create more and better drugs for cancer patients. We now have less than £14m to raise and urgently need your support.
Sally is living with stage 4 melanoma. She tells her story.
Dr Olivia Rossanese feels strongly about diversity in science – and why it’s so important to continue to build on the strides we have made to encourage more women into science.